Cytek Biosciences Cash Flow Statement (2020-2026) | CTKB

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
2.67M1.42M-1.17M-2.16M-0.70M1.63M3.72M-6.84M-4.39M-6.46M5.50M-6.19M-10.43M0.96M9.60M-11.40M-5.58M-5.47M-44.03M-18.87M
Depreciation and Depletion (Quarter)
0.20M0.19M0.35M0.30M0.40M0.40M0.50M0.50M0.60M0.90M0.80M0.80M0.90M0.90M0.90M0.90M1.00M1.00M1.00M1.00M
Share-based Compensation (Quarter)
0.67M2.46M3.01M3.84M3.93M4.36M-12.13M4.70M5.92M-10.62M22.05M5.64M-5.64M1.64M1.08M6.63M6.79M5.64M5.53M
Deferred Taxes (Quarter)
-2.89M-0.34M-2.06M-2.63M38.58M-0.18M
Gains from Investment Securities (Quarter)
-0.08M-1.58M-2.12M-1.56M-1.40M-1.20M-1.18M-1.25M-1.58M-1.49M-1.61M-1.35M-1.21M-1.25M
Asset Writedowns and Impairment (Quarter)
-0.06M0.07M0.15M0.07M0.21M0.17M0.29M0.01M0.78M0.67M0.91M-0.98M1.72M0.31M-0.26M0.41M-0.05M0.19M
Cash from Operations (Quarter)
-3.91M1.16M5.45M-1.48M-9.44M-7.50M6.19M2.86M-2.85M-4.24M9.51M3.96M6.20M13.22M2.00M-0.12M0.11M-3.90M-0.77M-2.74M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.68M0.69M0.70M1.10M0.80M0.80M0.79M0.79M0.76M0.67M0.96M0.89M1.01M1.10M1.14M1.15M0.95M
Depreciation & Amortization (CF) (Quarter)
0.20M0.19M0.69M0.79M0.86M0.07M0.76M1.00M1.65M1.77M1.63M1.70M1.81M1.85M1.85M1.88M1.89M1.92M1.90M1.86M
Change in Working Capital
Change in Receivables (Quarter)
8.29M5.59M0.72M1.04M6.93M3.82M7.96M-6.05M6.80M6.85M-0.26M-4.24M-5.92M6.25M9.33M-6.45M-0.65M0.59M6.15M-9.64M
Change in Inventory (Quarter)
0.26M0.96M2.23M5.92M8.43M5.18M-1.88M3.19M-3.03M1.89M-6.33M-4.77M-4.43M-3.56M-2.00M1.50M3.57M2.22M-2.05M1.63M
Change in Account Payables (Quarter)
-0.26M0.64M-0.74M2.78M0.90M-0.91M-0.91M0.30M-2.00M1.71M-1.79M0.61M-0.52M2.23M0.26M0.41M0.76M0.59M-1.31M0.39M
Change in Accured Expenses (Quarter)
0.37M1.59M8.88M0.56M2.23M0.04M4.64M1.76M-1.49M0.34M0.12M-4.60M-4.79M5.63M2.94M-2.12M2.79M-1.41M4.71M-3.89M
Change in Taxes (Quarter)
0.18M
Other Working Capital Changes (Quarter)
2.08M4.08M3.38M4.35M4.31M6.37M4.33M0.14M3.03M-0.83M7.18M2.92M-2.34M1.49M0.74M0.15M1.43M0.28M1.74M-3.85M
Investing Activities
Capital Expenditures (Quarter)
-0.17M2.73M1.30M0.23M1.88M1.11M6.53M0.14M-0.11M3.12M-3.11M0.57M1.05M-1.52M0.08M0.23M-0.19M3.04M-2.95M2.17M
Sales of Property, Plant and Equipment (Quarter)
0.08M0.02M0.19M0.03M0.02M0.00M0.20M0.01M
Acquisitions (Quarter)
44.90M0.00M0.47M
Change in Acquisitions & Divestments (Quarter)
10.00M68.00M54.00M72.00M40.00M38.00M45.00M70.43M66.47M79.20M76.11M70.71M
Cash from Investing Activities (Quarter)
-1.25M-1.31M-18.30M-0.78M-2.92M-1.15M-51.06M-168.87M2.79M43.12M29.07M-5.75M2.02M-15.81M-63.43M9.45M-16.41M18.92M-1.84M-27.08M
Financing Activities
Other financing activities (Quarter)
0.13M215.37M0.36M0.45M0.23M0.17M0.20M0.76M0.16M0.34M0.51M0.22M0.15M0.14M0.04M0.06M0.14M0.09M0.02M
Cash from Financing Activities (Quarter)
-3.72M217.08M0.02M0.36M1.14M0.15M3.85M0.22M-8.27M-33.75M1.61M-1.71M-12.08M-3.64M-11.54M-2.60M1.94M-1.23M3.98M
Additional items
Exchange Rate Effect (Quarter)
0.15M-0.01M0.68M-0.22M-1.40M0.13M-1.00M-1.09M-1.01M1.47M-0.82M1.70M2.26M-0.94M1.52M-1.23M-0.92M0.85M1.41M0.65M
Change in Cash (Quarter)
-8.74M-204.38M409.15M-2.11M-12.61M-8.37M-42.02M-167.11M-0.85M32.09M4.00M1.51M8.78M-15.62M-63.56M-3.45M-19.83M17.81M-2.43M-25.19M
Free Cash Flow (Quarter)
-3.74M-1.57M4.15M-1.71M-11.32M-8.61M-0.34M2.72M-2.74M-7.36M12.62M3.39M5.15M14.74M1.92M-0.36M0.30M-6.94M2.18M-4.90M
Net Cash Flow (Quarter)
-8.89M216.93M-12.83M-1.90M-11.21M-8.50M-41.02M-166.02M0.16M30.61M4.82M-0.18M6.51M-14.67M-65.08M-2.22M-18.91M16.96M-3.84M-25.83M